NCT00154869 Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C Status UNKNOWN Phase PHASE3
NCT00153881 Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer Status COMPLETED Phase PHASE1
NCT00150904 Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP) Status COMPLETED Phase N/A
NCT00150891 Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection Status COMPLETED Phase N/A
NCT00148915 A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo Status COMPLETED Phase PHASE4
NCT00148863 Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C Status COMPLETED Phase PHASE2
NCT00147836 Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients Status COMPLETED Phase NA
NCT00145561 The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-infected Pregnant Women. Status COMPLETED Phase PHASE1/PHASE2
NCT00142480 Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer Status COMPLETED Phase PHASE2
NCT00141037 Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation Status COMPLETED Phase PHASE1/PHASE2
NCT00139360 Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma Status COMPLETED Phase PHASE2
NCT00130533 Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer Patients Status COMPLETED Phase PHASE3
NCT00130507 Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With Trastuzumab Status TERMINATED Phase PHASE2
NCT00129935 EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer Status COMPLETED Phase PHASE3
NCT00129922 Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer Status COMPLETED Phase PHASE3